Re: Hojjat Ahmadzadehfar, Markus Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.028 (European Urology)
We read with great interest the report by Ahmadzadehfar and Essler  on the high prostate cancer detection rate with 68Ga-labeled prostate-specific membrane antigen (PSMA) ligand in positron emission tomography (PET) and its effect on treatment planning. The authors state that 68Ga-PSMA PET imaging is a perfect test in prostate cancer diagnosis and therapy planning. We would like to take this opportunity to address some issues.